SSG Group
12.1.2021 14:41:18 CET | Globenewswire | Press release
PRESS RELEASE
12 January 2021
Results from written procedure for BidCo af 28.04.2017 A/S
On 9 December 2020, BidCo af 28.04.2017 A/S (the "Company ") instructed Nordic Trustee & Agency AB (publ) (the "Agent ") for the Company's EUR 50,000,000 senior secured floating rate bonds due 2024 with ISIN SE0013234325 (the "Bonds ") to initiate a written procedure to request the bondholders to vote in favor of certain amendments, waivers and consents of the terms and conditions of the Bonds. The purpose of the amendments, waivers and consents is, amongst others, to:
(i) amend the amount of the permitted debt under the Bonds; and
(ii) waive any breach of certain terms of the Bonds.
All of the Bondholders that were voting in the written procedure voted in favor of the written procedure. It is therefore resolved that the written procedure has been approved.
Further information
For further questions, please contact: CEO Carsten Fensholt, e-mail Carsten.Fensholt@ssg.dk
, or Group CFO Pernille Damm, e-mail Pernille.d.Nielsen@ssg.dk
.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
StoneX Group Inc.9.9.2026 09:00:00 CEST | Press release
Launch of StoneX Trading marks a new era for City Index
Værdipapirfonden BankInvest9.9.2026 08:37:39 CEST | Pressemeddelelse
Værdipapirfonden BankInvest – Prospektopdatering
Wonderful Copenhagen9.9.2026 08:00:00 CEST | Press release
Ready, Set, Carb: Copenhagen fuels world championship runners with large pasta portions
Pharming Group N.V.9.9.2026 08:00:00 CEST | Press release
Pharming Group to participate in September investor conferences
ONWARD Medical NV9.9.2026 07:30:00 CEST | Press release
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
